Tachykinin receptors as therapeutic targets in stress-related disorders

K Ebner, SB Sartori, N Singewald - Current pharmaceutical …, 2009 - ingentaconnect.com
The first report demonstrating the therapeutic efficacy of an orally applied neurokinin-1
(NK1) receptor antagonist in depression was published 10 years ago. Although there were …
被引用次数：145 相关文章

[引用][C] Tachykinin Receptors as Therapeutic Targets in Stress-Related Disorders

K Ebner, S Sartori, N Singewald - Current Pharmaceutical Design, 2009 - cir.nii.ac.jp
Tachykinin Receptors as Therapeutic Targets in Stress-Related Disorders | CiNii Research
CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データを …

Tachykinin receptors as therapeutic targets in stress-related disorders

K Ebner, SB Sartori… - Current pharmaceutical …, 2009 - pubmed.ncbi.nlm.nih.gov
The first report demonstrating the therapeutic efficacy of an orally applied neurokinin-1
(NK1) receptor antagonist in depression was published 10 years ago. Although there were …

Tachykinin receptors as therapeutic targets in stress-related disorders.

K Ebner, SB Sartori, N Singewald - Current Pharmaceutical Design, 2009 - europepmc.org
The first report demonstrating the therapeutic efficacy of an orally applied neurokinin-1
(NK1) receptor antagonist in depression was published 10 years ago. Although there were …

[引用][C] Tachykinin Receptors as Therapeutic Targets in Stress-Related Disorders

K EBNER, SB SARTORI… - Current pharmaceutical …, 2009 - pascal-francis.inist.fr
Tachykinin Receptors as Therapeutic Targets in Stress-Related Disorders CNRS Inist
Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple search Advanced …

[引用][C] Tachykinin Receptors as Therapeutic Targets in Stress-Related Disorders

K EBNER, SB SARTORI, N SINGEWALD - Current pharmaceutical design, 2009 - Bentham